Cited by 581Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

The DOI matches its Crossref record; 215 of the 216 references it cites were found in a registry or an index.

Amyloid-β-independent regulators of tau pathology in Alzheimer disease

Open access

van der Kant, Rik, Goldstein, Lawrence S. B., Ossenkoppele, Rik·2020·Nature reviews. Neuroscience

DOI 10.1038/s41583-019-0240-3

Open this paper in CoChat — free account

Abstract

The global epidemic of Alzheimer disease (AD) is worsening, and no approved treatment can revert or arrest progression of this disease. AD pathology is characterized by the accumulation of amyloid-β (Aβ) plaques and tau neurofibrillary tangles in the brain. Genetic data, as well as autopsy and neuroimaging studies in patients with AD, indicate that Aβ plaque deposition precedes cortical tau pathology. Because Aβ accumulation has been considered the initial insult that drives both the accumulation of tau pathology and tau-mediated neurodegeneration in AD, the development of AD therapeutics has focused mostly on removing Aβ from the brain. However, striking preclinical evidence from AD mouse models and patient-derived human induced pluripotent stem cell models indicates that tau pathology can progress independently of Aβ accumulation and arises downstream of genetic risk factors for AD and aberrant metabolic pathways. This Review outlines novel insights from preclinical research that implicate apolipoprotein E, the endocytic system, cholesterol metabolism and microglial activation as Aβ-independent regulators of tau pathology. These factors are discussed in the context of emerging findings from clinical pathology, functional neuroimaging and other approaches in humans. Finally, we discuss the implications of these new insights for current Aβ-targeted strategies and highlight the emergence of novel therapeutic strategies that target processes upstream of both Aβ and tau.

Integrity signals

Registry

Crossref · 10.1038/s41583-019-0240-3

Cites

215 of 215 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
The amyloid hypothesis of Alzheimer's disease at 25 years
Selkoe, D. J., & Hardy, J. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201606210 · Cited by 6,164
A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease
Keren-Shaul, H., Spinrad, A., Weiner, A., Matcovitch-Natan, O., Dvir-Szternfeld, R., Ulland, T. K., David, E., Baruch, K., Lara-Astaiso, D., Toth, B., et al. (2017) · Cell · doi:10.1016/j.cell.2017.05.018 · Cited by 5,493
Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles
Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative Diseases
Krasemann, S., Madore, C., Cialic, R., Baufeld, C., Calcagno, N., El Fatimy, R., Beckers, L., O’Loughlin, E., Xu, Y., Fanek, Z., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.08.008 · Cited by 2,979

Show all 216 references

Research works printed but not linked: 7

Kemp, A. Update on phase III clinical trials of lanabecestat for Alzheimer’s disease. AstraZeneca https://www.astrazeneca.com/media-centre/press-releases/2018/update-on-phase-iii-clinical-trials-of-lanabecestat-for-alzheimers-disease-12062018.html (2018).
Jansen, W. J. et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. JAMA 313, 1924–1938 (2015). This large meta-analysis provides prevalence estimates of Aβ positivity in cognitively normal persons and patients with MCI. · DOI · Paper page
Cho, H. et al. Progressive tau accumulation in Alzheimer’s disease: two-year follow-up study. J. Nucl. Med. 60, 1611–1621 (2019). · DOI · Paper page
Hutter-Paier, B. et al. The ACAT inhibitor CP-113,818 markedly reduces amyloid pathology in a mouse model of Alzheimer’s disease. Neuron 44, 227–238 (2004). This study shows that cholesteryl esters can drive accumulation of Aβ pathology in AD mice and that ACAT inhibitors have potential utility in the treatment of AD. · DOI · Paper page
Mecozzi, V. J. et al. Pharmacological chaperones stabilize retromer to limit APP processing. Nat. Chem. Biol. 10, 443–449 (2014). This revolutionary biochemical study uses in silico screening to discover a small molecule that is capable of stabilizing the retromer complex. · DOI · Paper page
Shi, Y. et al. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy. Nature 549, 523–527 (2017). This elegant mouse study shows that the ApoE*4 genotype affects tau pathology in the absence of Aβ pathology. · DOI · Paper page
Santacruz, K. et al. Tau suppression in a neurodegenerative mouse model improves memory function. Science 309, 476–481 (2005). This is the first study to show that reducing tau expression in tau transgenic mice can rescue neuronal loss and behavioural deficits, even when extensive neurofibrillary tangles are already present. · DOI · Paper page

Sorted by citations

Items 401–500 of 581

Amyloid‐β but not tau accumulation is strongly associated with longitudinal cognitive decline
Wang, W., Huang, J., Qian, S., Zheng, Y., Yu, X., Jiang, T., Ai, R., Hou, J., Ma, E., Cai, J., et al. (2024) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14860 · Cited by 5
Brazilian kefir fraction mitigates the Alzheimer-like phenotype in Drosophila melanogaster with β-amyloid overexpression model
Malta, S. M., Rodrigues, T. S., Silva, M. H., Marquez, A. S., Ferreira, R. B., Mascarenhas, F. N. A. D. P., Zanon, R. G., Bernardes, L. M. M., Batista, L. L., da Silva, M. N. T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-76601-9 · Cited by 4
Revealing Cortical Spreading Pathway of Neuropathological Events by Neural Optimal Mass Transport
Dan, T., Huang, Y., Yang, Y., & Guorong Wu, A. (2025) · IEEE Transactions on Medical Imaging · doi:10.1109/tmi.2025.3558691 · Cited by 4
Discovery of fluorescent and theranostic probes for glycogen synthase kinase-3β in living cells and brain tissues: Detection and imaging in models of Alzheimer's disease
Chen, Y., Dong, H., 黄筱玲, Jiang, L., Jiang, Z., Li, L., Hu, J., & Chen, W.-H. (2025) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2025.117639 · Cited by 4
Neurophysiological Progression in Alzheimer's Disease: Insights From Dynamic Causal Modelling of Longitudinal Magnetoencephalography
Jafarian, A., Karadag, M., Kocagöncü, E., Lanskey, J. H., Fye, H. K. S., Williams, R., Quinn, A. J., Pitt, J., Raymont, V., Lowe, S. L., et al. (2025) · Human Brain Mapping · doi:10.1002/hbm.70234 · Cited by 6
Sea Cucumber Egg Oligopeptides Ameliorate Cognitive Impairments and Pathology of Alzheimer’s Disease Through Regulating HDAC3 and BDNF/NT3 via the Microbiota–Gut–Brain Axis
Zhang, G., Dou, Y., Xie, H., Pu, D., Wang, L., Wang, R., & Han, X. (2025) · Nutrients · doi:10.3390/nu17142312 · Cited by 4
PI31 expression is neuroprotective in a mouse model of early-onset parkinsonism
Rodríguez, J. A. R., Minis, A., Aref, R., Nguyen, H. H. M., Sun, F., & Steller, H. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2511899122 · Cited by 4
Physical exercise protects neurons from energy deficit and improves cognitive function by upregulating astrocytic Slc2a1 in Alzheimer's disease
Li, S., Zheng, F., Liu, S., Wu, R., Zhang, L., He, X., Li, M., & Li, L. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115493 · Cited by 5
Irisin-mediated hepatic autophagy remodels nutritional metabolism to prevent cognitive dysfunction
Zhang, X., Yang, Y., Song, H., Hu, X., Wang, X., & Yu, Y. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102936 · Cited by 4
Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance
Huang, Y., Chan, H., Khoo, J.-Y., Chan, M.-L., Bender, D. A., Ponnusamy, V. K., Belaidi, A. A., & Ke, L. (2025) · Neurochemistry International · doi:10.1016/j.neuint.2025.106104 · Cited by 4
Associations of Plasma Tau with Amyloid and Tau PET: Results from the Community-Based Framingham Heart Study
Ramos‐Cejudo, J., Scott, M. R., Tanner, J. A., Pase, M. P., McGrath, E. R., Ghosh, S., Osorio, R. S., Thibault, E. G., Fakhri, G. E., Johnson, K. A., et al. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-231320 · Cited by 5
Unveiling Potential Biomarkers in Cerebrospinal Fluid for Amyloid Pathological Positivity in Non-Demented Individuals
Meng, F., & Zhang, X. (2024) · The Journal of Prevention of Alzheimer s Disease · doi:10.14283/jpad.2024.129 · Cited by 4
Effect of Genetic Risk on the Relationship Between rs-fMRI Complexity and Tau and Amyloid PET in Alzheimer’s Disease
Jann, K., Cen, S., Santos, M. D. V., Aksman, L., Wijesinghe, D., Zhang, R., Lynch, K. M., Ringman, J. M., Wang, D. J. J., & Initiative, A. D. N. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240459 · Cited by 4
Anatomical, Physiological, and Pathological Changes in Different Parts of the Brain in Alzheimer's Disease
Shirian, S., Tahmasebian, N., Moghadam, B. B., Kiani, F. Z., & Amini, M. R. (2024) · The Neuroscience Journal of Shefaye Khatam · doi:10.61186/shefa.12.3.103 · Cited by 4
The role of oxidative stress in the development of Alzheimer's disease
Nikolenko, V. N., Rizaeva, N. A., Bulygin, K. V., Anokhina, V. M., & Bolotskaya, A. A. (2022) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2022-4-68-74 · Cited by 6
Hydroxycoumarins and some Flavonoids from Pistacia atlantica Desf. as Multi-targets Inhibitors for Alzheimer’s Disease: Molecular Docking and ADMET Studies
Lamrani, M., Serseg, T., Benarous, K., Sifi, I., & Yousfi, M. (2022) · Current Computer - Aided Drug Design · doi:10.2174/1573409919666221104093218 · Cited by 4
PET Amyloid and Tau Status Are Differently Affected by Patient Features
Tan, M., Initiative, A. D. N., Yang, Y., Wang, H.-F., Xu, W., Tan, C., Zuo, C., Dong, Q., Tan, L., & Yu, J. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200124 · Cited by 4
Association between long‐term donepezil treatment and brain regional amyloid and tau burden among individuals with mild cognitive impairment assessed using 18 F‐AV‐45 and 18 F‐AV‐1451 PET
Li, J., Zheng, C., Ge, Q., Yan, S., Paranjpe, M. D., Hu, S., Zhou, Y., & Initiative, A. D. N. (2021) · Journal of Neuroscience Research · doi:10.1002/jnr.24995 · Cited by 4
Blocking Microglial Proliferation by CSF-1R Inhibitor Does Not Alter the Neuroprotective Effects of Adoptive Regulatory T Cells in 3xTg Alzheimer’s Disease Mice
Park, S.-Y., Cha, N., Kim, S., Chae, S., Lee, W.-J., Jung, H., & Bae, H. (2024) · Current Issues in Molecular Biology · doi:10.3390/cimb46040180 · Cited by 3
Rivastigmine Templates with Antioxidant Motifs—A Medicinal Chemist’s Toolbox Towards New Multipotent AD Drugs
Dias, I., Emmanuel, M., Vogt, P., Guerreiro-Oliveira, C., Melo-Marques, I., Cardoso, S. M., Guedes, R. C., Chaves, S., & Santos, M. A. (2025) · Antioxidants · doi:10.3390/antiox14080921 · Cited by 3
Gut microbiota-dependent 24-hydroxycholesterol metabolism contributes to capsaicin-induced amelioration of Alzheimer’s disease-like pathology in mice
Li, Y., Wang, H., Zhang, D., Wang, S., Li, Z., Li, J., Tai, S., Tong, D., Wang, B., Lu, D., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-68937-9 · Cited by 5
Senescence as a Central Node in Alzheimer’s Disease: Molecular Triggers, Cellular Effectors, and RNA-Based Interventions
Some, A., Naskar, N., Thomas, D. M., Jeengar, M. K., & Nassar, A. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04737-3 · Cited by 3
Characterizing ferrous versus ferric iron in Alzheimer's disease using X-ray fluorescence imaging and XANES spectroscopy
Tran, D. Q., Georgiadis, M., DiGiacomo, P., Nirschl, J., Cobos, I., Rosenberg, J., Edwards, N. P., Bone, S., Webb, S. M., & Zeineh, M. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877261435561 · Cited by 3
PROTACs for central nervous system disorders: challenges and opportunities
Zheng, N., Shao, J., Xiong, B., Wei, Y., Wang, X., Zhou, Y., Song, Z., Zhang, A., Xu, C., Zhao, Q., et al. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118703 · Cited by 4
Jiaohong pills attenuate neuroinflammation and amyloid‐β protein‐induced cognitive deficits by modulating the mitogen‐activated protein kinase/nuclear factor kappa‐B pathway
Zhang, H., Cai, W., Dong, L., Yang, Q., Li, Q., Ran, Q., Liu, L., Wang, Y., Li, Y., Weng, X., et al. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12369 · Cited by 3
Apolipoprotein E4 interferes with lipid metabolism to exacerbate depression‐like behaviors in 5xFAD mice
Gong, Y., Li, M., Liu, M., Wu, X., Li, Y., Qin, C., & Zhang, L. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12446 · Cited by 3
Combination of RNA-seq and proteomics reveals the mechanism of DL0410 treatment in APP/PS1 transgenic mouse model of Alzheimer's disease
Zhang, B., Zhao, J., Yan, C., Bai, Y., Guo, P., Wang, C., Wang, Z., Du, G., & Liu, A. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116940 · Cited by 3
L1CAM mimetic compound duloxetine improves cognitive impairment in 5xFAD mice and protects Aβ1-42-damaged HT22 cells
Chen, H., Fang, Z., Lin, S. L., & Schachner, M. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177476 · Cited by 3
Molecular dynamics of amyloid-β transport in Alzheimer's disease: Exploring therapeutic plasma exchange with albumin replacement – Current insights and future perspectives
Mondal, R., Deb, S., Shome, G., Sarkar, V., Lahiri, D., Datta, S. S., & Benito‐León, J. (2025) · Neurología (English Edition) · doi:10.1016/j.nrleng.2025.03.008 · Cited by 3
Brain tau PET-based identification and characterization of subpopulations in patients with Alzheimer’s disease using deep learning-derived saliency maps
Li, Y., Wang, X., Ge, Q., Graeber, M. B., Yan, S., Li, J., Li, S., Gu, W., Hu, S., Benzinger, T. L. S., et al. (2025) · EJNMMI Physics · doi:10.1186/s40658-025-00761-4 · Cited by 3
The interaction between resilience framework and neuron-astrocyte-synapse dynamics in AD
Ma, H., Zhao, H., Feng, X., & Gao, F. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1644532 · Cited by 4
Characterization of the brain lipidome associated with frontotemporal lobar degeneration MAPT P301S mutation
Juanes, A. M., Vogels, T., Hertog, S. K.-D., Loos, M., Lütjohann, D., Giera, M. A., & van der Kant, R. (2025) · Journal of Lipid Research · doi:10.1016/j.jlr.2025.100952 · Cited by 3
Phytotherapeutics Attenuation of Oxidative Stress, Inflammation and Lipid Peroxidation in Severe and Chronic Diseases
Mavondo, G. A., Ncube, N., Sibanda, A., Dube, D., Chikuse, F. F., & Makoni, P. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99832 · Cited by 6
An Artificial Intelligence‐Based Motion Trajectory Prediction of Fibrous Matters
Yang, S., & Ling, S. (2021) · Advanced Intelligent Systems · doi:10.1002/aisy.202100136 · Cited by 3
Deep-learning assessment of hippocampal magnetic susceptibility in Alzheimer's disease
Shibata, H., Uchida, Y., Kan, H., Sakurai, K., Madokoro, Y., Iwano, S., Maurya, S. K., Muñoz-González, Á., Ardakani, I., Yamada, K., et al. (2024) · Journal of Alzheimer s Disease · doi:10.1177/13872877241300278 · Cited by 3
Tau pathway‐based gene analysis on PET identifies CLU and FYN in a Korean cohort
Yi, D., Byun, M. S., Park, J., Kim, J., Jung, G., Ahn, H., Lee, J., Lee, Y., Kim, Y., Kang, K. M., et al. (2024) · Alzheimer s & Dementia · doi:10.1002/alz.14416 · Cited by 3
Connectomics and neurotransmitter receptor profile explain regional tau pathology in Alzheimer’s disease
Nabizadeh, F., & Initiative, A. D. N. (2025) · Cerebral Cortex · doi:10.1093/cercor/bhaf053 · Cited by 3
Elevated 24-hydroxycholesterol levels counteract okadaic acid-induced tau hyperphosphorylation and neuronal morphology impairment
Giannelli, S. G., Eroli, F., Loera‐Valencia, R., Leoni, V., Latorre‐Leal, M., Testa, G., Staurenghi, E., Sottero, B., Gamba, P., Maioli, S., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107029 · Cited by 3
Does Loss of Integrity of the Cingulum Bundle Link Amyloid-β Accumulation and Neurodegeneration in Alzheimer’s Disease?
Vlegels, N., Ossenkoppele, R., van der Flier, W. M., Koek, H. L., Reijmer, Y. D., Wisse, L. E. M., Biessels, G. J., & Initiative, T. A. D. N. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220024 · Cited by 3
Self-citation
Predicting future regional tau accumulation in asymptomatic and early Alzheimer’s diseasePreprint
Giorgio, J., Jagust, W. J., Baker, S. L., Landau, S. M., Peter Tiňo, B., Kourtzi, Z., & Initiative, A. D. N. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.21203/rs.3.rs-60371/v1 · Cited by 3
Can rapamycin slow down memory decline in Alzheimer’s disease with seizures?
Shetty, A. K. (2021) · Brain · doi:10.1093/brain/awab474 · Cited by 3
Interactive rather than independent effect of APOE and sex potentiates tau deposition in women
Wang, Y., Pascoal, T. A., Therriault, J., Kang, M.-S., Benedet, A. L., Savard, M., Tissot, C., Lussier, F. Z., Arias, J. F., Mathotaarachchi, S. S., et al. (2023) · doi:10.32920/24438049.v1 · Cited by 3
Understanding monocyte-driven neuroinflammation in Alzheimer’s disease using human brain organoid microphysiological systemsPreprint
Tian, C., Ao, Z., Cerneckis, J., Cai, H., Chen, L., Niu, H., Takayama, K., Kim, J., Shi, Y., Gu, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.16.638539 · Cited by 3
Cortical morphology changes in default mode network regions as predictors of cognitive decline in relation to amyloid and tau deposits
Menardi, A., Saglam, C., Rocca, B. L., Cecchin, D., Venneri, A., Cagnin, A., & Vallesi, A. (2025) · Brain Communications · doi:10.1093/braincomms/fcaf320 · Cited by 2
Unraveling the complexity of chronic diseases: an introductory exploration
Prajapati, C., Singh, P., Nand, S., & Singh, S. K. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33877-9.00005-7 · Cited by 2
Prediction of mild cognitive impairment progression using time-sensitive multimodal biomarkers
Gallego-Rudolf, J., Wiesman, A. I., Yakoub, Y., Zetterberg, H., Blennow, K., Baillet, S., & Villeneuve, S. (2026) · Science Advances · doi:10.1126/sciadv.aee2305 · Cited by 2
Brain topology alteration in Alzheimer’s disease brain networks: A multi-center study
Ma, L. Y., Wang, P., Wang, D., Yao, H., Zhou, B., Zhao, Y., Liao, Z., Chen, Y., Zhang, X., Han, Y., et al. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103919 · Cited by 2
Proteins Associated with Cognition in Amyloid-beta Positive Elders Based on Cerebrospinal Fluid Proteomics
Liu, M., Hu, H., Fu, Y., Chi, H., Huang, L.-Y., Tan, L., & Hu, H. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05442-y · Cited by 2
Free-water imaging predicts cognitive decline and clinical progression in cognitively normal older adults
He, H., Zhang, C., Yu, D., Gao, X., Wei, C., & Ding, W. (2026) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.121108 · Cited by 3
Long-term NRF2-driven microglial repopulation mitigates microgliosis, neuronal loss and cognitive deficits in tauopathy
Viqueira, L., Navarro, E., Negredo, P., Bernal, J. A., Rodrı́guez-Franco, M. I., Tortosa, E., & López, M. G. (2026) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2026.106253 · Cited by 2
TUDCA Ameliorates Cognitive Impairment in APP/PS1 Mice by Modulating the Microbiota–Gut–Brain Axis
Zhan, M., Chen, H., Fu, X., Tang, S., Song, X., Li, H., Zhu, L., & Wang, B. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48010087 · Cited by 3
Presenilin deficiency beyond amyloid: Lessons from presenilin 1/2 conditional double-knockout mice on synaptic failure, calcium dyshomeostasis, and inflammation-driven Alzheimer’s disease
Yang, G., Xu, X., & Xu, Y. (2026) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2026.112057 · Cited by 2
Clinical Significance of the Plasma Biomarker Panels in Amyloid-Negative and Tau PET-Positive Amnestic Patients: Comparisons with Alzheimer’s Disease and Unimpaired Cognitive Controls
Chang, H., Huang, K., Huang, C.-G., Huang, C., Huang, S., Lin, K., & Chang, C. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115607 · Cited by 2
A Risk Variant rs6922617 in TREM Is Discrepantly Associated With Defining Neuropathological Hallmarks in the Alzheimer’s Continuum
Qian, S., Zheng, Y., Jiang, T., Hou, J., Cao, R., Cai, J., Ma, E., Wang, W., Song, W., & Xie, C. (2024) · The Journals of Gerontology Series A · doi:10.1093/gerona/glae185 · Cited by 2
Autoimmune hypothesis of Alzheimer’s disease: unanswered question
Arshavsky, Y. I. (2024) · Journal of Neurophysiology · doi:10.1152/jn.00259.2024 · Cited by 2
Copper and its isotopes: a brief overview of its implications in geology, environmental system, and human health
Srivastava, T., & Wanjari, N. (2024) · Isotopes in Environmental and Health Studies · doi:10.1080/10256016.2024.2410290 · Cited by 3
Tau in Health and Neurodegenerative Diseases
Chu, D., & Liu, F. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.101299 · Cited by 2
Association Study of Apolipoprotein E Gene Polymorphism With Incidence and Delayed Resolution of Hemifacial Spasm
Zhou, J., Jiang, L., Yuan, S., Huang, J., Shi, Q., Xie, Y., Deng, B., & Zhan, Y. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.760126 · Cited by 2
Altern und neurodegenerative Erkrankungen – warum gehen Nervenzellen verloren?
Klimaschewski, L. P. (2021) · Springer eBooks · doi:10.1007/978-3-662-63392-2_2 · Cited by 2
Gastrointestinal biopsy of normal mucosa or nonspecific inflammation and risk of neurodegenerative disease: Nationwide matched cohort study
Sun, J., Ludvigsson, J. F., Roelstraete, B., Pedersen, N. L., Yudi Pawitan, Y., Wirdefeldt, K., & Fang, F. (2022) · European Journal of Neurology · doi:10.1111/ene.15654 · Cited by 2
Understanding Alzheimer’s Disease by Targeting Gut Microbiota and Role of Heavy Metals: Insight from Novel Therapeutical Approach
Bhratee, A., Kumar, M., Alam, M. R., Anand, P., & Singh, S. (2023) · Current Pharmacology Reports · doi:10.1007/s40495-023-00325-z · Cited by 2
Par-4 in Neuronal Death and Survival in Alzheimer’s Disease and Other Neurogenerative Diseases
Guo, Q., Xie, J., & Guo, C. J. (2021) · Springer eBooks · doi:10.1007/978-3-030-80558-6_14 · Cited by 2
A mechanistic model explains oscillatory slowing and neuronal hyperactivity in Alzheimer’s diseasePreprint
Alexandersen, C. G., de Haan, W., Bick, C., & Goriely, A. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.06.20.496731 · Cited by 2
Elevated gonadotropin levels are associated with increased biomarker risk of Alzheimer’s disease in midlife womenPreprint
Nerattini, M., Rubino, F., Jett, S., Andy, C., Boneu, C., Zarate, C., Carlton, C., Kodancha, V., Loeb‐Zeitlin, S., Havryliuk, Y., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-2351642/v1 · Cited by 2
The role of ADAR editing and nonsense-mediated decay in Parkinson’s DiseasePreprint
Mercer, H., Nair, A. M., Tariq, A., & Piontkivska, H. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.05.17.594716 · Cited by 2
Sortilin C-terminal fragment deposition depicts tangle-related nonamyloid neuritic plaque growth in Alzheimer’s diseasePreprint
Zhang, Q., Wang, Y., Coulibaly, S., Sun, Z.-P., Cai, X.-L., Tu, T., Liu, Y., Pan, A., Cui, M., Manavis, J., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.11.622955 · Cited by 2
Hebbian plasticity: The elusive missing link at the heart of Alzheimer’s disease pathogenesis?
Jeans, A. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.340402 · Cited by 1
Silencing NRBP1 Gene with shRNA Improves Cognitive Function and Pathological Features in AD Rat Model
Wei, X., Liu, X., Ban, Y., Li, J., & Rong, H. (2025) · Biochemical Genetics · doi:10.1007/s10528-025-11169-1 · Cited by 1
Immune system-associated genes in patients with Alzheimer's disease
Yao, R., Ouyang, Z., Xu, T., Zhu, Y., Tang, B., Li, J., Jiao, B., Shen, L. H., Luo, S., & Xiao, X. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251364396 · Cited by 1
Variations in ADAR editing of nonsense-mediated decay targets in PD males and females
Mercer, H., Nair, A. M., Tariq, A., & Piontkivska, H. (2025) · F1000Research · doi:10.12688/f1000research.168181.1 · Cited by 1
Docosahexaenoic acid ameliorates mild cognitive impairment mediated by cannabinoid receptor 1-ceramide axis
Wang, Y.-P., Liu, P., Chen, Y., Wang, Y., Cong, Y., Wen, H., Liu, M., Guo, X., & Li, D. (2025) · Food Science and Human Wellness · doi:10.26599/fshw.2025.9250802 · Cited by 1
Integrative analysis of cerebrospinal fluid biomarkers, metabolomics, and polygenic risk reveals novel metabolite associations with Alzheimer's disease
Francia, M., Ramesh, N., Boltz, T. A., Bot, M. H. M., van der Flier, W. M., Visser, P. J., van der Lee, S. J., Teunissen, C. E., Pijnenburg, Y. A. L., den Braber, A., et al. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251389924 · Cited by 2
Increases in brain catecholamine levels counteract memory deficits and reduces Aβ deposition in 5XFAD male mice
Cho, E., Yi, J. H., Jeon, S. J., Kim, D., Kwon, H., Jeon, J., Kwon, K. J., Jang, D. P., Moon, M., Shin, C. Y., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118764 · Cited by 1
Circadian rhythm of amyloid-β in the olfactory bulb and cerebellum of wild-type and APPxPS1 knock-in mice indicates a loss of rhythmicity in regions more vulnerable to amyloid pathology
Buzinova, V. A., Johnson, C. E., Turton, S. M., Barth, S. E., Padgett, S., Jessup, M. T., Köhler, K., Whitlock, H. R., Bachstetter, A. D., Sunderam, S., et al. (2025) · Biogerontology · doi:10.1007/s10522-025-10359-z · Cited by 1
Carrier-free nanoassembly with dual antioxidant and anti-inflammatory activities camouflaged by melanoma cell membrane for tau-targeted therapy of Alzheimer's disease
Xue, R., Wang, F., Zhang, B., Wu, J., Zhang, N., & Sun, C. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123970 · Cited by 3
Relationships between heritable dementia risk factors, cardiovascular risk factors in young adulthood, and midlife neuropsychological outcomes
Koychev, I. G., Vaci, N., Moonen, J. E. F., Reid, G., Howgego, G., Yaffe, K. S., Nasrallah, I. M., Sidney, S. S., Jindra, C., Gallacher, J., et al. (2026) · Journal of Alzheimer s Disease · doi:10.1177/13872877251401482 · Cited by 1
Choroid plexus structural and functional abnormalities correlate with disease severity and cognition in cerebral small vessel disease
Luo, D., Wang, X., Peng, Y., Zeng, P., Zeng, B., Li, B., Nie, L., Luo, T., & Li, Y. (2026) · Neuroradiology · doi:10.1007/s00234-026-03922-z · Cited by 1
IL-1β neutralization ameliorates cognitive deficits and tau pathology in a mouse model of Alzheimer's disease with hyperhomocysteinemia
Zhao, Y., Chen, W., & Zhou, F. (2026) · Experimental Neurology · doi:10.1016/j.expneurol.2026.115729 · Cited by 1
Whole-genome sequencing reveals an East Asian-specific rare variant of INPP5J associated with Alzheimer’s disease
Kimura, T., Yamakawa, A., Mitsumori, R., Niida, S., Ozaki, K., & Shigemizu, D. (2026) · Translational Psychiatry · doi:10.1038/s41398-026-04027-0 · Cited by 1
Ameliorative effect of AYUSH formulation against scopolamine induced learning and memory impairment in rat via attenuation of oxidative stress, neuroinflammation, acetylcholinesterase inhibition and Aβ plaques
Samal, M., Zahiruddin, S., Srivastava, V., Penumallu, N. R., Parveen, B., Parveen, R., Ansari, S. H., & Ahmad, S. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.121853 · Cited by 1
Coaggregation with Aβ Drives β-Sheet Formation in tau Microtubule-Binding Repeats
Huang, F., Liu, Y., Wang, Y., Lv, Z., Xu, J. Y., Zhang, J., Ding, F., & Sun, Y. (2026) · Biomacromolecules · doi:10.1021/acs.biomac.5c02524 · Cited by 1
Artificial intelligence in biomarker discovery for diseases: diagnostic and therapeutic prospects
Dinç, R., & Ardıç, N. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02946-4 · Cited by 1
Aging and Neurodegenerative Diseases: Why do Nerve Cells Die?
Klimaschewski, L. P. (2022) · Springer eBooks · doi:10.1007/978-3-662-66369-1_2 · Cited by 1
Consumo de medicamentos para doença de Alzheimer no mercado privado brasileiro
de Freitas, E. L., Calil-Eliás, S., Erbisti, R. S., Grinberg-Weller, B., & Miranda, E. S. (2023) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2023057005128 · Cited by 4
Presenilin deficiency enhances tau phosphorylation and its secretion
Sun, Y., Islam, S., Gao, Y., Nakamura, T., Tomita, T., Michikawa, M., & Zou, K. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16155 · Cited by 2
TESC overexpression mitigates amyloid-β-induced hippocampal atrophy and memory decline
Qi, J., Suo, X., Tian, C., Xia, X., Qin, W., Wang, P., Tang, J., Xu, J., Fu, J., Liu, N., et al. (2024) · Gene · doi:10.1016/j.gene.2024.148939 · Cited by 1
Recent advances in neurodegenerative disease research
Singh, E., & Dilawari, R. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28822-7.00014-3 · Cited by 1
Role of Liver in Alzheimer’s Disease
(2020) · ARC Journal of Neuroscience · doi:10.20431/2456-057x.0403003 · Cited by 1
Cholesterol and Dementia: A Possible Therapeutic Approach
Alavez-Rubio, J. S., & Juárez‐Cedillo, T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_13 · Cited by 1
PI31 expression prevents neuronal degeneration in a mouse Parkinson Disease modelPreprint
Minis, A., & Steller, H. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.05.078832 · Cited by 1
Molecular Modeling Tools Used for the Prediction of Amyloid-Β Fibrils Disaggregating Molecules from Plant SourcesPreprint
Rakesh, U. L., Kumar, G. A., Theivendren, P., Pavadai, P., Veerachamy, S., Palanisamy, P., Bandral, S. K., Alagarsamy*, S. K. K., & Kunjiappan, S. (2024) · Preprints.org · doi:10.20944/preprints202409.0119.v1 · Cited by 1
Incremental Value of Plasma Biomarkers in Predicting Clinical Decline Among Cognitively Unimpaired Older Adults: Results from the A4 trialPreprint
Khorsand, B., Ghanbarian, E., Rabin, L. A., Sajjadi, S. A., & Ezzati, A. (2025) · medRxiv · doi:10.1101/2025.07.22.25332015 · Cited by 1
Bundle-specific associations between white matter microstructure and Aβ and tau pathology at their connecting cortical endpoints in older adults at risk of Alzheimer’s diseasePreprint
Binette, A. P., Theaud, G., Rheault, F., Roy, M., Collins, D. L., Breitner, J. C. S., Poirier, J., Descoteaux, M., & Villeneuve, S. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.08.27.266551
Neuronal NOX4 knockdown alleviates pathological tau-related alterations in a humanized mouse model of tauopathyPreprint
Luengo, E., Trigo-Alonso, P., Fernández‐Mendívil, C., Núñez, Á., del Campo, M., Porrero, C., García‐Magro, N., Negredo, P., Sánchez‐Ramos, C., Bernal, J. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.10.14.338954
Lipid membranes from naked mole-rat brain lipids are cholesterol-rich, highly phase-separated, and sensitive to amyloid-induced damagePreprint
Frankel, D. J., Davies, M., Bhushan, B., Kulaberoglu, Y., Urriola‐Muñoz, P., Bertrand‐Michel, J., Pergande, M. R., Smith, A. A., Preet, S., Park, T. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.06.05.134973
Characterization of Tau ELISAs for Evaluating Tau Accumulation in the Brains With Alzheimer’s DiseasePreprint
Shinohara, M., Hirokawa, J., Shimodaira, A., Tashiro, Y., Suzuki, K., Fukumori, A., Matsubara, T., Morishima, M., Saito, Y., Murayama, S., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-149164/v1
IN VITRO STUDIES ON THE PROTECTIVE EFFECT OF TANNIC ACID OF U87 CELLS INDUCED BY BETA-AMYLOID
Özbolat, G., & Alizade, A. (2021) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.990503
Polygenic effect on accelerated tau pathology accumulation in Alzheimer’s disease: implications for patient selection in clinical trialsPreprint
Rubinski, A., Frerich, S., Malik, R., Franzmeier, N., Ramírez, A., Dichgans, M., Ewers, M., & Initiative, A. D. N. (2021) · medRxiv · doi:10.1101/2021.11.02.21265788
The Relationship Between Funcation Connectivity and Amyloid Accumulation in AD Continuum
Ling, R., Yang, Y., Wei, L., & Fan, C. (2021) · International Congress on Image and Signal Processing (CISP) · doi:10.1109/cisp-bmei53629.2021.9624445
Synthesis of Florbetapir aza-analogues using chemistry of pyridinium N-aminides
Gala, E., Recio, J., Álvarez‐Buílla, J., & Izquierdo, M. L. (2021) · ARKIVOC · doi:10.24820/ark.5550190.p011.676

Authors: van der Kant, R., Goldstein, L. S. B., & Ossenkoppele, R.
Affiliations: University of California San Diego (US)
Lund University (SE)
ORCID: van der Kant, Rik
Goldstein, Lawrence S. B.
Ossenkoppele, Rik
Venue: Nature reviews. Neuroscience
Publisher: Springer Science and Business Media LLC
Published: 2019-11-28
Volume: 21
Issue: 1
Pages: 21-35
ISSN: 1471-003X (ISSN-L)
1471-0048
DOI: 10.1038/s41583-019-0240-3
OpenAlex: W2989855650
Cited by: 580
References: 216
Citations by year: 2026: 57 · 2025: 89 · 2024: 93 · 2023: 89 · 2022: 95 · 2021: 95 · 2020: 61
FWCI: 7.39
Type: journal article
Language: en
Open access: green
research.vu.nl
Licence: other-oa
www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Nature reviews. Neuroscience (publishedVersion)
PubMed (publishedVersion)
VU Research Portal (publishedVersion, other-oa)
Lund University Publications (Lund University) (submittedVersion)
Amsterdam UMC (VU Amsterdam) - Institutional Repository (submittedVersion)
Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
Data Archiving and Networked Services (DANS) (submittedVersion)
Funders: National Institute on Aging (RF1AG048083)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords: Alzheimer's disease, tau pathology, amyloid-beta, apolipoprotein E, cholesterol metabolism, microglial activation, induced pluripotent stem cell models, mouse model
MeSH terms: Alzheimer Disease, Animals, Apolipoproteins E, Cholesterol, Endocytosis, Humans, Amyloid beta-Peptides, tau Proteins, Microglia, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Amyloid-β-independent regulators of tau pathology in Alzheimer disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks